publication date: Feb. 11, 2011
• ODAC Calls for Tougher Standards for Accelerated Approval in Oncology • Sponsors Withdraw Indications for Iressa, Celebrex
• Doroshow: NCI Leaves it up to Groups to Make their own Merger Deals • White House yet to Name NCAB, Cancer Panel Members • NCI Largely Unaffected by NIH Translational Research Center
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.